Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic.
Munger Clary HM, Croxton RD, Allan J, Lovato J, Brenes G, Snively BM, Wan M, Kimball J, Wong MH, O'Donovan CA, Conner K, Jones V, Duncan P. Munger Clary HM, et al. Among authors: allan j. Epilepsy Behav. 2020 Mar;104(Pt A):106907. doi: 10.1016/j.yebeh.2020.106907. Epub 2020 Jan 27. Epilepsy Behav. 2020. PMID: 32000099 Free PMC article.
Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample.
Munger Clary HM, Croxton RD, Snively BM, Brenes GA, Lovato J, Sadeghifar F, Kimball J, O'Donovan C, Conner K, Kim E, Allan J, Duncan P. Munger Clary HM, et al. Among authors: allan j. Epilepsy Behav. 2021 Jan;114(Pt A):107543. doi: 10.1016/j.yebeh.2020.107543. Epub 2020 Nov 24. Epilepsy Behav. 2021. PMID: 33246893 Free PMC article.
Odronextamab monotherapy in R/R DLBCL after progression with CAR T-cell therapy: Primary analysis of the ELM-1 study.
Topp MS, Matasar MJ, Allan JN, Ansell SM, Barnes JA, Arnason JE, Michot JM, Goldschmidt N, O'Brien SM MD, Abadi U, Avivi I, Cheng Y, Flink DM, Zhu M, Brouwer-Visser J, Chaudhry A, Mohamed H, Ambati S, Crombie JL. Topp MS, et al. Among authors: allan jn. Blood. 2024 Dec 30:blood.2024027044. doi: 10.1182/blood.2024027044. Online ahead of print. Blood. 2024. PMID: 39786390
Phenotypic evolution of SARS-CoV-2 spike during the COVID-19 pandemic.
Furnon W, Cowton VM, De Lorenzo G, Orton R, Herder V, Cantoni D, Ilia G, Mendonca DC, Kerr K, Allan J, Upfold N, Meehan GR, Bakshi S, Das UR, Molina Arias S, McElwee M, Little S, Logan N, Kwok K, Smollett K, Willett BJ, Da Silva Filipe A, Robertson DL, Grove J, Patel AH, Palmarini M. Furnon W, et al. Among authors: allan j. Nat Microbiol. 2025 Jan;10(1):77-93. doi: 10.1038/s41564-024-01878-5. Epub 2025 Jan 3. Nat Microbiol. 2025. PMID: 39753670
The potential of cognitive remediation therapy for improving the communication capabilities of adults with schizophrenia and other psychotic spectrum disorders.
McGuiness A, Travethan L, Irvin K, Black Y, Apps J, Corinth K, Kennedy J, Brown VZ, Morgan C, Quartly-Scott G, Rensburg PV, Rusten K, Gott C, Lappin J, Sugden N, Allan J, Dark F, Gray H, Thomas G, Hollow A, Thomas M. McGuiness A, et al. Among authors: allan j. Int J Lang Commun Disord. 2025 Jan-Feb;60(1):e13141. doi: 10.1111/1460-6984.13141. Int J Lang Commun Disord. 2025. PMID: 39651878
1,328 results